Vanessa Giannone

1.7k citations
11 papers · 1.3k · 1 hit paper · h-index 7

Impact in

Papers in

Vanessa Giannone

11 papers receiving 1.3k citations

Vanessa Giannone's Hit Papers

Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial 2017 · 975 citations
9750+3+6Years since publication250500750

Peers

Vanessa Giannone
Comparison fields: 5 of 59
  • Pulmonary and Respiratory Medicine 646
  • Oncology 506
  • Cancer Research 235
  • Genetics 148
  • Pathology and Forensic Medicine 166
Replace Pamela Drullinsky with:
Pamela Drullinsky United States
J. Garcia‐Vargas United States
Jessica Orf United States
Lone H. Ottesen United States
Marlies H.G. Langenberg Netherlands
V. Damiano Italy
Scott R. McDonnell United States
Zhenfan Yang China
Clive Morris United Kingdom
Pingkuan Zhang United States
Vanessa Giannone relative to Pamela Drullinsky United States Pamela Drullinsky's profile →
Citations per field
00.5×3.4×
Pamela Drullinsky · 1×
Citations per year

Countries citing papers authored by Vanessa Giannone

Since Specialization
Citations

This map shows the geographic impact of Vanessa Giannone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Giannone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Giannone more than expected).

Fields of papers citing papers by Vanessa Giannone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Giannone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Giannone. The network helps show where Vanessa Giannone may publish in the future.

Co-authors

The 25 scholars most cited alongside Vanessa Giannone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vanessa Giannone Line = papers co-authored together Vanessa Giannone links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
Hit paper breakdown →
2017975
2 201170
3 201961
4 201160
5 201337
6 201735
7 201424
8 20174
9 20103
10 20102
11 20131

About Vanessa Giannone

Vanessa Giannone is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Organic Chemistry, Epidemiology and Hematology, having authored 11 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (4 papers), Lung Cancer Treatments and Mutations (3 papers), Click Chemistry and Applications (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Iron Metabolism and Disorders (2 papers), Folate and B Vitamins Research (1 paper), Bone and Joint Diseases (1 paper) and Erythropoietin and Anemia Treatment (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (646 citations), Oncology (506 citations), Cancer Research (235 citations), Genetics (148 citations) and Pathology and Forensic Medicine (166 citations). Vanessa Giannone has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Egbert F. Smit, Bijoyesh Mookerjee, Julien Mazières, Bruce E. Johnson, Anthony M. D’Amelio, Harry J.M. Groen, David Planchard, Benjamin Besse, Pingkuan Zhang and Åslaug Helland. Their work appears in journals such as Blood, Gastroenterology, British Journal of Haematology, Journal of Thoracic Oncology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact